The digital transformation of quality-by-design assessment workflows can improve efficiency, reduce human errors, and facilitate integration within a much broader digital ecosystem.
Gayathri Acharya
Advertisement
Gayathri Acharya is scientific leader, QbD and digital platforms, medicines development and supply at GSK Upper Providence, Collegeville, PA, USA.
Articles by Gayathri Acharya
Advertisement
Latest Updated Articles
Digitalization of QbD Risk AssessmentsPublished: March 16th 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Welcome to CPHI Frankfurt 2025
2
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
